Biogen (BIIB) Short-Term Debt issuances (2009 - 2011)
Biogen (BIIB) posted Short-Term Debt issuances of -$1000.0 for Q4 2011, down 100.02% on a QoQ basis from $4.2 million in Q3 2011, and down 100.05% year-over-year from $1.9 million in Q4 2010.
Analysis
Biogen (BIIB) Short-Term Debt issuances (2009 - 2011) Analysis & Trends
Biogen has reported Short-Term Debt issuances for 3 years, with the latest figure at -$1000.0 in Q4 2011.
- On a quarterly basis, Short-Term Debt issuances fell 100.05% year-over-year to -$1000.0 in Q4 2011; TTM through Dec 2011 was $11.5 million, a 36.6% decrease from a year earlier, with the FY2012 full-year figure at $2.4 million, down 78.81% from the prior year.
- Short-Term Debt issuances was -$1000.0 for Q4 2011 at Biogen, down from $4.2 million in the prior quarter.
- The five-year high for Short-Term Debt issuances was $12.1 million in Q2 2010, with the low at -$2.5 million in Q1 2011.
- Average Short-Term Debt issuances over 3 years is $3.8 million, with a median of $2.0 million recorded in 2010.
- The largest YoY upside for Short-Term Debt issuances was 106.47% in 2011 against a maximum downside of 222.63% in 2011.
- Over 3 years, Short-Term Debt issuances stood at $1.4 million in 2009, then soared by 34.3% to $1.9 million in 2010, then sank by 100.05% to -$1000.0 in 2011.
- The last three Short-Term Debt issuances figures came in at -$1000.0 (Q4 2011), $4.2 million (Q3 2011), and $9.7 million (Q2 2011), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Insmed | 27.67 Bn | 26.51 Bn | 358.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2011 | -1,000.00 |
| Sep 30, 2011 | 4.21 Mn |
| Jun 30, 2011 | 9.71 Mn |
| Mar 31, 2011 | -2.47 Mn |
| Dec 31, 2010 | 1.89 Mn |
| Sep 30, 2010 | 2.04 Mn |
| Jun 30, 2010 | 12.13 Mn |
| Mar 31, 2010 | 2.01 Mn |
| Dec 31, 2009 | 1.41 Mn |
| Jun 30, 2009 | 9.50 Mn |
| Mar 31, 2009 | 1.37 Mn |